Jubilant Biosys appoints Venugopala Reddy Pagadala as VP&CFO - CRDMO
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
Subscribe To Our Newsletter & Stay Updated